{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"maridebart-cafraglutide","name":"Maridebart cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":23,"objects":{"clinicaltrials-gov-nct06660173-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06660173-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct06660173-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06660173-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct06660173-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct06660173-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct06660173-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-09-11","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06660173","sourceIds":["ctg-observation-nct06660173-2026-09-11-dfcf2dd8720e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06660173 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-11, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct06660173-2026-09-11-dfcf2dd8720e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06660173 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-11, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct06660173-2026-09-11-dfcf2dd8720e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06660173-2026-09-11-dfcf2dd8720e"]}],"sources":[{"id":"ctg-observation-nct06660173-2026-09-11-dfcf2dd8720e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06660173 · retained source version 2026-09-11:dfcf2dd8720eee75605fef185ae1153439869797ef1a2e2f6d827aef846b701b","url":"https://clinicaltrials.gov/study/NCT06660173"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d15f13f694c6d979a0c40c65054953a85710b52a18a1d29c4ddf275b571cb2cc","tierARecordSha256":"8958eda2c1751c38e3218ecead7aa552c40d9681c33c2f8e2b49a3ae1476370a"},"integrity":{"algorithm":"sha256","contentSha256":"8d15b4e79c75a97282d34f7b78dcd2612220dc6aed659d65b84739a75c1f3858"}},"clinicaltrials-gov-nct06858839-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06858839-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct06858839-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06858839-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct06858839-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct06858839-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct06858839-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-09-17","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06858839","sourceIds":["ctg-observation-nct06858839-2026-09-17-beb2c75eb0a3"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06858839 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-17, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct06858839-2026-09-17-beb2c75eb0a3"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06858839 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-17, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct06858839-2026-09-17-beb2c75eb0a3"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06858839-2026-09-17-beb2c75eb0a3"]}],"sources":[{"id":"ctg-observation-nct06858839-2026-09-17-beb2c75eb0a3","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06858839 · retained source version 2026-09-17:beb2c75eb0a3bc43ffe1b4c9fab269e89fcf8ae6cbe11f7d4c3ea4213aed3e04","url":"https://clinicaltrials.gov/study/NCT06858839"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e4eb41de5c6e384554cf3038f95a4b1396bb3f606a3be63e0d4d689bbb667ef0","tierARecordSha256":"47e62562ca71078e70dc841591a80eb3c35301e7d3a8b63ed08cdfc3007ef229"},"integrity":{"algorithm":"sha256","contentSha256":"d5319106c8efa27c12308bc42a1cd17fd8c9316862afa46880e2d85883588caf"}},"clinicaltrials-gov-nct06987695-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06987695-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct06987695-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06987695-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct06987695-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct06987695-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct06987695-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2025-12-17","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06987695","sourceIds":["ctg-observation-nct06987695-2025-12-17-6b02adf2b965"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06987695 at 2026-07-30T18:18:33.507Z. Its registry update date was 2025-12-17, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct06987695-2025-12-17-6b02adf2b965"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06987695 at 2026-07-30T18:18:33.507Z. Its registry update date was 2025-12-17, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct06987695-2025-12-17-6b02adf2b965"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06987695-2025-12-17-6b02adf2b965"]}],"sources":[{"id":"ctg-observation-nct06987695-2025-12-17-6b02adf2b965","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06987695 · retained source version 2025-12-17:6b02adf2b9653a7e1104f8657f56e6753e437be3897ab65b54cbc4c013f2bc18","url":"https://clinicaltrials.gov/study/NCT06987695"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"65940a3bb225b949e6a529cda0770e05371ab55bdf520dee12c557129198e076","tierARecordSha256":"cffc50d51067a3c639cd30c1fff710e4690f55ce589973a90ab210f35daf0d5f"},"integrity":{"algorithm":"sha256","contentSha256":"5a91ff8681233ec7ede0a9b976294754fe49fc0dcaad3aebcf7d7314a3a7a865"}},"clinicaltrials-gov-nct07037433-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07037433-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07037433-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07037433-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07037433-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07037433-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07037433-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-07-24","sourceCheckedAt":"2026-08-10","publishedAt":"2026-08-13","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07037433","sourceIds":["ctg-observation-nct07037433-2026-07-24-ae9704758762"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07037433 at 2026-08-10T18:10:03.862Z. Its registry update date was 2026-07-24, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07037433-2026-07-24-ae9704758762"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07037433 at 2026-08-10T18:10:03.862Z. Its registry update date was 2026-07-24, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07037433-2026-07-24-ae9704758762"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07037433-2026-07-24-ae9704758762"]}],"sources":[{"id":"ctg-observation-nct07037433-2026-07-24-ae9704758762","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07037433 · retained source version 2026-07-24:ae9704758762002a715a9ed9f57da8845f1a2ea224c8296b8200071653366d78","url":"https://clinicaltrials.gov/study/NCT07037433"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"76c5134e8feeb2e769fddb8720f26f459292148c745276b8d1dc291565a0826f","tierARecordSha256":"adfa67774d01184acf6627482dd3596373b492b84e56052ae569880d0945f068"},"integrity":{"algorithm":"sha256","contentSha256":"7f41469849b715bd4deda9da6f54470b11b435f0c067a82399f5344adb548201"}},"clinicaltrials-gov-nct07037459-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07037459-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07037459-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07037459-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07037459-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07037459-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07037459-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-07-02","sourceCheckedAt":"2026-08-10","publishedAt":"2026-08-13","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07037459","sourceIds":["ctg-observation-nct07037459-2026-07-02-199638062a19"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07037459 at 2026-08-10T18:10:04.222Z. Its registry update date was 2026-07-02, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07037459-2026-07-02-199638062a19"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07037459 at 2026-08-10T18:10:04.222Z. Its registry update date was 2026-07-02, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07037459-2026-07-02-199638062a19"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07037459-2026-07-02-199638062a19"]}],"sources":[{"id":"ctg-observation-nct07037459-2026-07-02-199638062a19","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07037459 · retained source version 2026-07-02:199638062a19e7df645ce1f76202d15ba272ee303ca7769667116afd6858e958","url":"https://clinicaltrials.gov/study/NCT07037459"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0203da8119d91d96f7bf08c2b6f650e8abbb71c0afe3460b6847f11da9e366be","tierARecordSha256":"c925ddc5b3c424f07dea6fe44f1da40eafe891acef5c91f0ae80d377fc4047ad"},"integrity":{"algorithm":"sha256","contentSha256":"26332b63ecd6182595dc26b2444412e9b616f701d33d5aa367b46be43c71a072"}},"clinicaltrials-gov-nct07225686-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07225686-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07225686-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07225686-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07225686-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07225686-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07225686-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-06-12","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-08","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07225686","sourceIds":["ctg-observation-nct07225686-2026-06-12-50c5d117af0d"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07225686 at 2026-07-30T16:19:03.064Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07225686-2026-06-12-50c5d117af0d"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07225686 at 2026-07-30T16:19:03.064Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07225686-2026-06-12-50c5d117af0d"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07225686-2026-06-12-50c5d117af0d"]}],"sources":[{"id":"ctg-observation-nct07225686-2026-06-12-50c5d117af0d","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07225686 · retained source version 2026-06-12:50c5d117af0dc48b2dd50fb0b65e9d36906883af0c94c88c6c3b44d9da0c56f5","url":"https://clinicaltrials.gov/study/NCT07225686"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e91daa2e3a54cc0fe58e29617cdcfb84d4ee6b0c9f7f531497f250bd16658ff6","tierARecordSha256":"59780bca7b405b8d419607975630048d2d4eca90dc6ac2eb743a73d67c3a33d6"},"integrity":{"algorithm":"sha256","contentSha256":"68f54de41146b78d8031936bba3c399be626f18b343972c2e2c10cfe91b8d071"}},"clinicaltrials-gov-nct07226765-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07226765-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07226765-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07226765-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07226765-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07226765-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07226765-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-06-12","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07226765","sourceIds":["ctg-observation-nct07226765-2026-06-12-7e841bc432b4"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07226765 at 2026-07-30T16:19:03.046Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07226765-2026-06-12-7e841bc432b4"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07226765 at 2026-07-30T16:19:03.046Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07226765-2026-06-12-7e841bc432b4"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07226765-2026-06-12-7e841bc432b4"]}],"sources":[{"id":"ctg-observation-nct07226765-2026-06-12-7e841bc432b4","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07226765 · retained source version 2026-06-12:7e841bc432b47bbab67050e3d0fad0b2eb875d796eedd4f2f6deedf391de2317","url":"https://clinicaltrials.gov/study/NCT07226765"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4df23e4bd37e694bc93a2178600f3f7d97cbbee00045bfa25dbeeb1279bb5337","tierARecordSha256":"5aa59c25d120d5d4215b0ce9f391f6a76a8f41bb0a1fc5f18a0f0ce16d900e7d"},"integrity":{"algorithm":"sha256","contentSha256":"f5fd5a6e09be15806d805592c47d27aafd7e71407da29e57ae489110e89f6244"}},"clinicaltrials-gov-nct07229157-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07229157-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07229157-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07229157-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07229157-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07229157-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07229157-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-01-23","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07229157","sourceIds":["ctg-observation-nct07229157-2026-01-23-ad418d0b577e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07229157 at 2026-07-30T16:25:18.016Z. Its registry update date was 2026-01-23, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07229157-2026-01-23-ad418d0b577e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07229157 at 2026-07-30T16:25:18.016Z. Its registry update date was 2026-01-23, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07229157-2026-01-23-ad418d0b577e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07229157-2026-01-23-ad418d0b577e"]}],"sources":[{"id":"ctg-observation-nct07229157-2026-01-23-ad418d0b577e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07229157 · retained source version 2026-01-23:ad418d0b577ec2136f82a066a578858c0a65ab076199537cdfc170e950808516","url":"https://clinicaltrials.gov/study/NCT07229157"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"bf85c0adba9efd254601c18c24c9b57671a394c1b02fad2f01c4833d2844699c","tierARecordSha256":"e23d9772fd6bc536217878e3d8b4ebd42368a31c31cc278c8e48a360343fa235"},"integrity":{"algorithm":"sha256","contentSha256":"f037ec7d162db632a0d0253f247f087a2bf79fded1674378589d218b2cfaa828"}},"clinicaltrials-gov-nct07310563-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07310563-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07310563-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07310563-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07310563-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07310563-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07310563-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-10-13","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07310563","sourceIds":["ctg-observation-nct07310563-2026-10-13-d3d2a53a7dee"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07310563 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07310563-2026-10-13-d3d2a53a7dee"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07310563 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07310563-2026-10-13-d3d2a53a7dee"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07310563-2026-10-13-d3d2a53a7dee"]}],"sources":[{"id":"ctg-observation-nct07310563-2026-10-13-d3d2a53a7dee","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07310563 · retained source version 2026-10-13:d3d2a53a7deeaaade829d9b50fff5d8d516b8f18546d3e7dfa49786b153d2578","url":"https://clinicaltrials.gov/study/NCT07310563"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"912fdb8b56d790268d5458ee7a1aee9c6b6638750ac22df5b3e8e5542b03ee64","tierARecordSha256":"eb25fb75564a2a964f373afb506185eb736c1e98a6932a8e4db51063cb18ae72"},"integrity":{"algorithm":"sha256","contentSha256":"bfa9b11a14b37cfe6f8db2f0dce82496b6fa604c86d30f1ea6e0fcdda120a009"}},"clinicaltrials-gov-nct07313761-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07313761-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07313761-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07313761-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07313761-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07313761-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07313761-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-08-07","sourceCheckedAt":"2026-08-13","publishedAt":"2026-08-14","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07313761","sourceIds":["ctg-observation-nct07313761-2026-08-07-e83b3d74dfe0"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07313761 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07313761-2026-08-07-e83b3d74dfe0"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07313761 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07313761-2026-08-07-e83b3d74dfe0"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07313761-2026-08-07-e83b3d74dfe0"]}],"sources":[{"id":"ctg-observation-nct07313761-2026-08-07-e83b3d74dfe0","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07313761 · retained source version 2026-08-07:e83b3d74dfe048cc939dbfd917b586a5a46559f5c3856ba40d9a8b6750899789","url":"https://clinicaltrials.gov/study/NCT07313761"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"93fa1679ac5cdef6e9be3104875445a75339ed2d261f2acdd20397f1b95d4011","tierARecordSha256":"d7b0e14f27e6143a004c57ae8d33b99d3a8945c50cb7d55b012f32f881542633"},"integrity":{"algorithm":"sha256","contentSha256":"d7c2ccb4749ccfa3930367dbb65ba3bb00433d0ca8791b2a6eab7a48c8809d52"}},"clinicaltrials-gov-nct07441252-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07441252-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07441252-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07441252-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07441252-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07441252-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07441252-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-06-18","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-08","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07441252","sourceIds":["ctg-observation-nct07441252-2026-06-18-204e72018406"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07441252 at 2026-07-30T16:19:03.063Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07441252-2026-06-18-204e72018406"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07441252 at 2026-07-30T16:19:03.063Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07441252-2026-06-18-204e72018406"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07441252-2026-06-18-204e72018406"]}],"sources":[{"id":"ctg-observation-nct07441252-2026-06-18-204e72018406","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07441252 · retained source version 2026-06-18:204e72018406561b9fd2daba448608e487fe397757a26dd95c32fdcdfedd48bd","url":"https://clinicaltrials.gov/study/NCT07441252"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"06f586e1e97291fc94f4538859dbf3a78d297444c1127c103f6b0680b4435174","tierARecordSha256":"93dc1fbb14fec6c706f7a97019d8e924b25f682dfd678899615f9b8e7bfb3084"},"integrity":{"algorithm":"sha256","contentSha256":"210ca801685ca0c4827090215ff7b38f4f41319160b7a08b7362fb653a31951f"}},"clinicaltrials-gov-nct07575399-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07575399-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07575399-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07575399-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07575399-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07575399-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07575399-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-08-27","sourceCheckedAt":"2026-09-09","publishedAt":"2026-09-09","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07575399","sourceIds":["ctg-observation-nct07575399-2026-08-27-17e49c29ef1e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07575399 at 2026-09-09T19:17:17.083Z. Its registry update date was 2026-08-27, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07575399-2026-08-27-17e49c29ef1e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07575399 at 2026-09-09T19:17:17.083Z. Its registry update date was 2026-08-27, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07575399-2026-08-27-17e49c29ef1e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07575399-2026-08-27-17e49c29ef1e"]}],"sources":[{"id":"ctg-observation-nct07575399-2026-08-27-17e49c29ef1e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07575399 · retained source version 2026-08-27:17e49c29ef1e4495861f7e35505c30761d39180accda58037a2b0a1c450c59f0","url":"https://clinicaltrials.gov/study/NCT07575399"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6613b700065d8501a29d9e9cbffa9a6a389d759a2c84911ee491bcc1453f70c3","tierARecordSha256":"e6d26d08e7151faa361fe4b244017e4d61b54cc31bb714aff24dfc710d3367c3"},"integrity":{"algorithm":"sha256","contentSha256":"9d0c3f9000eb2880e1d21020e7f9bacae14c439071aaa07d99cda0c3e33c1c92"}},"clinicaltrials-gov-nct07684144-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07684144-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07684144-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07684144-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07684144-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07684144-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07684144-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-09-03","sourceCheckedAt":"2026-09-09","publishedAt":"2026-09-09","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07684144","sourceIds":["ctg-observation-nct07684144-2026-09-03-55c606c96523"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07684144 at 2026-09-09T19:17:17.403Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07684144-2026-09-03-55c606c96523"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07684144 at 2026-09-09T19:17:17.403Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07684144-2026-09-03-55c606c96523"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07684144-2026-09-03-55c606c96523"]}],"sources":[{"id":"ctg-observation-nct07684144-2026-09-03-55c606c96523","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07684144 · retained source version 2026-09-03:55c606c96523ea42d404f5617e5f68a2c197af4f8392d7f3ab505d7bdf0c5e7a","url":"https://clinicaltrials.gov/study/NCT07684144"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"56993e1c91be3239819a7c943fc91e55919bb9e220a4a857ea04d789aebb86a5","tierARecordSha256":"06979e8be6c24550b2b37fb01ac59e7bad9df68d8fe85d56600b8dfc82285cec"},"integrity":{"algorithm":"sha256","contentSha256":"63ca2c491fa395f3d89f97e92b167c421bd5d67bde1b0943d9719cee831b7c85"}},"clinicaltrials-gov-nct07684235-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07684235-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07684235-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07684235-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07684235-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07684235-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07684235-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-08-04","sourceCheckedAt":"2026-08-13","publishedAt":"2026-08-14","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07684235","sourceIds":["ctg-observation-nct07684235-2026-08-04-8fc86edf161b"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07684235 at 2026-08-13T05:52:27.017Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07684235-2026-08-04-8fc86edf161b"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07684235 at 2026-08-13T05:52:27.017Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07684235-2026-08-04-8fc86edf161b"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07684235-2026-08-04-8fc86edf161b"]}],"sources":[{"id":"ctg-observation-nct07684235-2026-08-04-8fc86edf161b","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07684235 · retained source version 2026-08-04:8fc86edf161b19dd348d2fed7847cdbde4ce7abb7d1b1d08beb9b11fb77b82de","url":"https://clinicaltrials.gov/study/NCT07684235"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1af4c4b6397449142a862034511b6683046867f7d8c6b3081aa265a1314a7af1","tierARecordSha256":"96236ca69a1e75deceb93e8f80c5320d890d78f3f7665086d5196f6a47868679"},"integrity":{"algorithm":"sha256","contentSha256":"1ebbd7c8cf3dcc0d6caf52f57400c0c9ba3ad3f225b7e1b867e1cba77373bc26"}},"clinicaltrials-gov-nct07832799-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07832799-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07832799-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07832799-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07832799-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07832799-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07832799-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-09-22","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07832799","sourceIds":["ctg-observation-nct07832799-2026-09-22-8acd78d54982"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07832799 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-22, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07832799-2026-09-22-8acd78d54982"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07832799 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-22, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07832799-2026-09-22-8acd78d54982"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07832799-2026-09-22-8acd78d54982"]}],"sources":[{"id":"ctg-observation-nct07832799-2026-09-22-8acd78d54982","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07832799 · retained source version 2026-09-22:8acd78d54982c34b9c2c8eb6baccb025c928817131c93a9ec1fe078af4604f1e","url":"https://clinicaltrials.gov/study/NCT07832799"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2bd27cf112782a08d02e738fe0c116a112211b55762d6d5232d9a2c4e89ce5c4","tierARecordSha256":"c54b4226f69fd804ba6222dc9159e0658ed879e524a699888cb88b6f4b9caa82"},"integrity":{"algorithm":"sha256","contentSha256":"c750131c359b0bae1953a79c5a2f176f4a5b1beb3792928e383ed37e8cbb56fc"}},"clinicaltrials-gov-nct07871409-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07871409-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07871409-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07871409-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07871409-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07871409-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07871409-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-11-09","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07871409","sourceIds":["ctg-observation-nct07871409-2026-11-09-044f888fca47"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07871409 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07871409-2026-11-09-044f888fca47"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07871409 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07871409-2026-11-09-044f888fca47"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07871409-2026-11-09-044f888fca47"]}],"sources":[{"id":"ctg-observation-nct07871409-2026-11-09-044f888fca47","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07871409 · retained source version 2026-11-09:044f888fca4724ddbc09c5b974058539200e01bb960cb97ebd6993ba0f3adfdd","url":"https://clinicaltrials.gov/study/NCT07871409"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d57638688bc09b37b4324cf8e08520d62ffd734e3f83a472cd9d3813f49712ea","tierARecordSha256":"20a76d4525e2111899e4116d09924e67e3823fd15ae0202f81c473569551470d"},"integrity":{"algorithm":"sha256","contentSha256":"f5d178ea9005640871f0a89ff272e584b8d3d535bec0e05c60dca1828ee85cc4"}},"clinicaltrials-gov-nct07908316-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07908316-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07908316-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07908316-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07908316-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07908316-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07908316-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-11-02","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07908316","sourceIds":["ctg-observation-nct07908316-2026-11-02-a5d40d2df2f5"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07908316 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07908316-2026-11-02-a5d40d2df2f5"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07908316 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07908316-2026-11-02-a5d40d2df2f5"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07908316-2026-11-02-a5d40d2df2f5"]}],"sources":[{"id":"ctg-observation-nct07908316-2026-11-02-a5d40d2df2f5","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07908316 · retained source version 2026-11-02:a5d40d2df2f58ff9f08a1c94d622a6e9e412b047c2c782f6eeb000c48062ab20","url":"https://clinicaltrials.gov/study/NCT07908316"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c7abcb800fb12f0ba43d3ddd3355314e86e5ec9dd1b0e6d972db6fcf9bdcc55b","tierARecordSha256":"5da07265b53c0b53c8fc7d83423b59267f9147c50314348011b33372be36bbf3"},"integrity":{"algorithm":"sha256","contentSha256":"bac1b7fd3f621c7a08bb9271e6bdb278eec245a797f12dba599b5468e8706e61"}},"clinicaltrials-gov-nct07921316-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07921316-maridebart-cafraglutide:v1","objectPathId":"clinicaltrials-gov-nct07921316-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07921316-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#clinicaltrials-gov-nct07921316-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#clinicaltrials-gov-nct07921316-maridebart-cafraglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07921316-maridebart-cafraglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-11-06","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07921316","sourceIds":["ctg-observation-nct07921316-2026-11-06-6ee6f9853bc2"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07921316 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-06, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07921316-2026-11-06-6ee6f9853bc2"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07921316 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-06, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.","sourceIds":["ctg-observation-nct07921316-2026-11-06-6ee6f9853bc2"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07921316-2026-11-06-6ee6f9853bc2"]}],"sources":[{"id":"ctg-observation-nct07921316-2026-11-06-6ee6f9853bc2","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07921316 · retained source version 2026-11-06:6ee6f9853bc2eba93557db7a910d6356824dc3886fac3ed687adc42df6332c92","url":"https://clinicaltrials.gov/study/NCT07921316"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3acb1cc610591faf07a2486dab1bc2cb33e72b0a0bffa92bc98dbc2c61b6d42e","tierARecordSha256":"7a0180736fbfcaf4a964b653b03a1696d2b1fcde4b75344cf4fd73b7310402d6"},"integrity":{"algorithm":"sha256","contentSha256":"414af34a03e150478fae7efb7bb958ff4a44245e67e5e26dd67371e59de231c6"}},"maritide-bioavailability-study-updated-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:maritide-bioavailability-study-updated:v1","objectPathId":"maritide-bioavailability-study-updated-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/maritide-bioavailability-study-updated/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#maritide-bioavailability-study-updated-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#maritide-bioavailability-study-updated-v1"},"story":{"slug":"maritide-bioavailability-study-updated","version":1,"domain":"Clinical trials","dateInSource":"2026-07-21","sourceCheckedAt":"2026-07-22","publishedAt":"2026-07-22","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"MariTide bioavailability study record updated","sourceIds":["ctg-nct07717814-v1"]},{"id":"summary","text":"ClinicalTrials.gov lists a completed Maridebart cafraglutide study sponsored by Amgen.","sourceIds":["ctg-nct07717814-v1"]},{"id":"paragraph-1","text":"ClinicalTrials.gov lists the NCT07717814 record under Amgen. Its overall recruitment status was shown as completed when PeptideScanner reviewed the record.","sourceIds":["ctg-nct07717814-v1"]},{"id":"paragraph-2","text":"The registry shows 2026-07-21 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome.","sourceIds":["ctg-nct07717814-v1"]}],"sources":[{"id":"ctg-nct07717814-v1","name":"ClinicalTrials.gov","sourceClass":"A","title":"Bioavailability of AMG 133 in Participants With Overweight or Obesity · record history version 1 · last update posted 2026-07-21","url":"https://clinicaltrials.gov/study/NCT07717814?a=1&tab=history"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"07b8d3ff42eaeed83009b46e88b039fe953c6fcad2a7a38d007273319861f84f"},"integrity":{"algorithm":"sha256","contentSha256":"b328c4484505ed689dd9849477dfa71089fd41ca999d1c8b354fc2e6bbe30a76"}},"pubmed-pmid-41337722-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41337722-maridebart-cafraglutide:v1","objectPathId":"pubmed-pmid-41337722-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41337722-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#pubmed-pmid-41337722-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#pubmed-pmid-41337722-maridebart-cafraglutide-v1"},"story":{"slug":"pubmed-pmid-41337722-maridebart-cafraglutide","version":1,"domain":"Literature metadata","dateInSource":"2026-03-04","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-10","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 41337722","sourceIds":["pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 41337722 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 41337722 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092"]}],"sources":[{"id":"pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 41337722 · retained source version 1:2026-03-04:current:f7b75bc790922f4acc4a637f4e9e6977d30ccd90eace9b7c8f65b20018d96633","url":"https://pubmed.ncbi.nlm.nih.gov/41337722/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ba5f15a4f830a389463cef3cd68e0ce283c2a41e0154785b8db58d1dda4b169a","tierARecordSha256":"e829bb32c8bbf00989202d0cd2b0fff2823c0852a30ceff0aaf40d46a27d5c3a"},"integrity":{"algorithm":"sha256","contentSha256":"b9c325d5819f3d2f0dee0f6bfa11e35c072e4dfebb261e7dd8dbea44267d2fcc"}},"pubmed-pmid-41337723-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41337723-maridebart-cafraglutide:v1","objectPathId":"pubmed-pmid-41337723-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41337723-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#pubmed-pmid-41337723-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#pubmed-pmid-41337723-maridebart-cafraglutide-v1"},"story":{"slug":"pubmed-pmid-41337723-maridebart-cafraglutide","version":1,"domain":"Literature metadata","dateInSource":"2026-03-04","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-10","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 41337723","sourceIds":["pubmed-observation-pmid-41337723-2026-03-04-5c351ce6cff9"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 41337723 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-41337723-2026-03-04-5c351ce6cff9"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 41337723 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-41337723-2026-03-04-5c351ce6cff9"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41337723-2026-03-04-5c351ce6cff9"]}],"sources":[{"id":"pubmed-observation-pmid-41337723-2026-03-04-5c351ce6cff9","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 41337723 · retained source version 1:2026-03-04:current:5c351ce6cff93daab209f29bef7827712e519f8fe73f2e180bccf42dff33a511","url":"https://pubmed.ncbi.nlm.nih.gov/41337723/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"46f2c396b8cccafb8f8f959e01d89255e2144b8111568625d2b802806989be48","tierARecordSha256":"e5c6a87b850fe4469cacb67b6de721eda9c2a9c651f16c72c2fac1293e39dde4"},"integrity":{"algorithm":"sha256","contentSha256":"dc62143e5c6096b41f337b121d09e2f73267b105174a2057756791c614a9f1be"}},"pubmed-pmid-41337724-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41337724-maridebart-cafraglutide:v1","objectPathId":"pubmed-pmid-41337724-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41337724-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#pubmed-pmid-41337724-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#pubmed-pmid-41337724-maridebart-cafraglutide-v1"},"story":{"slug":"pubmed-pmid-41337724-maridebart-cafraglutide","version":1,"domain":"Literature metadata","dateInSource":"2025-12-03","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-10","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 41337724","sourceIds":["pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 41337724 at 2026-07-30T18:19:18.413Z. PubMed recorded a metadata revision date of 2025-12-03 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 41337724 at 2026-07-30T18:19:18.413Z. PubMed recorded a metadata revision date of 2025-12-03 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3"]}],"sources":[{"id":"pubmed-observation-pmid-41337724-2025-12-03-a4eeac53f0c3","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 41337724 · retained source version 1:2025-12-03:current:a4eeac53f0c35b4e52f5f0374d742523825106ce3160700deeaa8759f03915dc","url":"https://pubmed.ncbi.nlm.nih.gov/41337724/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1cea81517951091452d79c2f06edbba4e204f167c79ac6d0693909add379eb22","tierARecordSha256":"c316d0331b7d6a027540dc4075b0776c4167f31f65f991c853c74d1f11a212c5"},"integrity":{"algorithm":"sha256","contentSha256":"18c6faa8eebda557a09d764d600fda9175aeef65a3dac0c592fb46ec31f0295b"}},"pubmed-pmid-42592044-maridebart-cafraglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42592044-maridebart-cafraglutide:v1","objectPathId":"pubmed-pmid-42592044-maridebart-cafraglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42592044-maridebart-cafraglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.json#pubmed-pmid-42592044-maridebart-cafraglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/maridebart-cafraglutide.md#pubmed-pmid-42592044-maridebart-cafraglutide-v1"},"story":{"slug":"pubmed-pmid-42592044-maridebart-cafraglutide","version":1,"domain":"Literature metadata","dateInSource":"2026-08-13","sourceCheckedAt":"2026-08-13","publishedAt":"2026-08-13","peptideSlugs":["maridebart-cafraglutide"],"peptides":[{"slug":"maridebart-cafraglutide","url":"https://peptidescanner.com/peptides/maridebart-cafraglutide/"}]},"claims":[{"id":"headline","text":"Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.","sourceIds":["pubmed-observation-pmid-42592044-2026-08-13-41bdad779671"]},{"id":"summary","text":"PubMed lists PMID 42592044 in Antibody therapeutics as Journal Article, Review, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug maridebart-cafraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42592044-2026-08-13-41bdad779671"]},{"id":"paragraph-1","text":"PubMed lists PMID 42592044 in Antibody therapeutics as Journal Article, Review, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug maridebart-cafraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42592044-2026-08-13-41bdad779671"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42592044-2026-08-13-41bdad779671"]}],"sources":[{"id":"pubmed-observation-pmid-42592044-2026-08-13-41bdad779671","name":"PubMed","sourceClass":"A","title":"Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications. · retained source version 1:2026-08-13:current:41bdad7796714760059177aeeebb9c4217b2973c075002cc8d757619c91b8b6e","url":"https://pubmed.ncbi.nlm.nih.gov/42592044/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"abc8663a892569a0a9a7298e235d7d9b098f728cdeb260a62fe26a325dea6dce","tierARecordSha256":"9b9f07c8ef76e9145dd1d0c139f7e363f9ad1712d2f17769b7ff4a2c172554a8"},"integrity":{"algorithm":"sha256","contentSha256":"32b92034afda1af3af6e25573866b5a2fa58797cbc45223840aa81e288f59688"}}}}
